Skip to main content

Table 3 Agreement of patient- and proxy-ratings for the EORTC QLQ-BN20

From: Do neurooncological patients and their significant others agree on quality of life ratings?

EORTC QLQ-BN20 Patient Mean (SD) Proxy Mean (SD) Patient minus Proxy effect size t-value
p-value
Pearson-Correlation
(CI95%)
agreement (+/- 5 point)
Future Uncertainty 28.3 (29.6) 31.1 (28.1) -2.8 -0.10 t = -0.67;
p = 0.51
0.55*
(0.29-0.74)
29%
Visual Disorders 13.3 (16.5) 12.9 (19.9) 0.4 0.02 t = 0.16;
p = 0.88
0.58*
(0.34-0.76)
50%
Motor Dysfunction 21.1 (25.9) 21.8 (28.3) -0.7 -0.02 t = -0.20;
p = 0.84
0.67*
(0.46-0.81)
44%
Communication Deficits 26.3 (28.1) 23.8 (33.4) 2.5 0.08 t = 0.64;
p = 0.53
0.67*
(0.46-0.81)
45%
Headaches 34.1 (35.7) 32.5 (34.9) 1.6 0.04 t = 0.32;
p = 0.75
0.59*
(0.35-0.77)
57%
Seizures 13.5 (30.4) 7.1 (17.3) 6.3 0.27 t = 1.43;
p = 0.16
0.38*
(0.09-0.62)
81%
Drowsiness 38.9 (32.9) 36.5 (30.2) 2.4 0.08 t = 0.45;
p = 0.65
0.42*
(0.13-0.65)
38%
Hair Loss 9.2 (18.5) 7.5 (19.2) 1.7 0.09 t = 0.57;
p = 0.57
0.52*
(0.26-0.72)
78%
Itchy Skin 12.8 (22.4) 14.5 (29.4) -1.7 -0.07 t = -0.37;
p = 0.71
0.42*
(0.13-0.65)
64%
Weakness of Legs 25.0 (36.8) 21.7 (31.6) 3.3 0.10 t = 0.58;
p = 0.56
0.45*
(0.17-0.66)
60%
Bladder Control 10.0 (21.6) 6.7 (15.5) 3.3 0.18 t = 0.85;
p = 0.40
0.14
(-0.17-0.43)
75%
  1. *p < 0.05